Motegrity: payments to doctors
Payments that named Motegrity as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1M
- Providers
- 11,329
- Transactions
- 35,541
- Average per transaction
- $29
The per-transaction average — $29 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 11,329 providers the average total is $93, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $1,036,651 | 98.9% |
| Shire North American Group Inc | $11,724 | 1.1% |